Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not.

  • Authors : van Gelder T; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: .

Subjects: Calcineurin Inhibitors*/Calcineurin Inhibitors*/Calcineurin Inhibitors*/adverse effects ; Lupus Nephritis*/Lupus Nephritis*/Lupus Nephritis*/drug therapy; Adult

  • Source: Kidney international [Kidney Int] 2021 Dec; Vol. 100 (6), pp. 1185-1189. Date of Electronic Publication: 2021 Jul 17.Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up.

  • Authors : Argolini LM; Division of Clinical Rheumatology, ASST Istituto Gaetano Pini - CTO, Milan, Italy.; Frontini G

Subjects: Lupus Nephritis*/Lupus Nephritis*/Lupus Nephritis*/diagnosis ; Lupus Nephritis*/Lupus Nephritis*/Lupus Nephritis*/drug therapy ; Mycophenolic Acid*/Mycophenolic Acid*/Mycophenolic Acid*/adverse effects

  • Source: Journal of nephrology [J Nephrol] 2021 Apr; Vol. 34 (2), pp. 389-398. Date of Electronic Publication: 2020 May 27.Publisher: Springer Country of Publication: Italy NLM ID: 9012268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1724-6059

Record details

×
Academic Journal

Low-dose cyclosporine for active lupus nephritis: a dose titration approach.

  • Authors : Sumethkul K; Rheumatology Unit, Department of Medicine, Rajavithi Hospital, College of Medicine, Rangsit University, Rajavithi Road, Bangkok, 10400, Thailand. .; Kitumnuaypong T

Subjects: Cyclosporine/Cyclosporine/Cyclosporine/*administration & dosage ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*administration & dosage ; Lupus Nephritis/Lupus Nephritis/Lupus Nephritis/*drug therapy

  • Source: Clinical rheumatology [Clin Rheumatol] 2019 Aug; Vol. 38 (8), pp. 2151-2159. Date of Electronic Publication: 2019 Apr 01.Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949

Record details

×
Academic Journal

Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy.

  • Authors : Mao Y; Nephrology and Rheumatology Department, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Yin L

Subjects: Antibiotics, Antineoplastic/Antibiotics, Antineoplastic/Antibiotics, Antineoplastic/*therapeutic use ; Cyclosporine/Cyclosporine/Cyclosporine/*therapeutic use ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use

  • Source: The Journal of international medical research [J Int Med Res] 2019 Jan; Vol. 47 (1), pp. 105-113. Date of Electronic Publication: 2018 Sep 12.Publisher: Sage Publications Country of Publication: England NLM ID: 0346411 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis.

  • Authors : Jesus D; 1 Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.; Rodrigues M

Subjects: Cyclosporine/Cyclosporine/Cyclosporine/*administration & dosage ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*administration & dosage ; Kidney/Kidney/Kidney/*drug effects

  • Source: Lupus [Lupus] 2018 Jul; Vol. 27 (8), pp. 1358-1362. Date of Electronic Publication: 2018 Feb 15.Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis.

  • Authors : Sheikholeslami M; a Connective Tissue Diseases Research Center , Tabriz University of Medical Sciences , Tabriz , Iran.; Hajialilo M

Subjects: Cyclosporine/Cyclosporine/Cyclosporine/*therapeutic use ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use ; Lupus Nephritis/Lupus Nephritis/Lupus Nephritis/*drug therapy

  • Source: Modern rheumatology [Mod Rheumatol] 2018 May; Vol. 28 (3), pp. 523-529. Date of Electronic Publication: 2017 Jul 28.Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus.

Subjects: Cyclosporine/Cyclosporine/Cyclosporine/*administration & dosage ; Lupus Erythematosus, Systemic/Lupus Erythematosus, Systemic/Lupus Erythematosus, Systemic/*complications ; Lupus Nephritis/Lupus Nephritis/Lupus Nephritis/*drug therapy

  • Source: Clinical nephrology [Clin Nephrol] 2018 Apr; Vol. 89 (4), pp. 277-285.Publisher: Dustri-Verlag Dr. Karl Feistle Country of Publication: Germany NLM ID: 0364441 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A.

  • Authors : Závada J; 1Institute of Rheumatology and First Faculty of Medicine, Charles University in Prague, Czech Republic.; Sinikka Pesicková S

Subjects: Cyclophosphamide/Cyclophosphamide/Cyclophosphamide/*adverse effects ; Cyclosporine/Cyclosporine/Cyclosporine/*adverse effects ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*adverse effects

  • Source: Lupus [Lupus] 2014; Vol. 23 (1), pp. 69-74. Date of Electronic Publication: 2013 Nov 08.Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis.

  • Authors : Kamijo Y; Department of Nephrology Internal Medicine, Shinshu University School of Medicine, Nagano, Japan. ; Hashimoto K

Subjects: Cyclosporine/Cyclosporine/Cyclosporine/*therapeutic use ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use ; Kidney/Kidney/Kidney/*pathology

  • Source: Clinical nephrology [Clin Nephrol] 2011 Aug; Vol. 76 (2), pp. 136-43.Publisher: Dustri-Verlag Dr. Karl Feistle Country of Publication: Germany NLM ID: 0364441 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study.

  • Authors : Zavada J; Institute of Rheumatology and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. ; Pesickova S

Subjects: Cyclophosphamide*/Cyclophosphamide*/Cyclophosphamide*/administration & dosage ; Cyclophosphamide*/Cyclophosphamide*/Cyclophosphamide*/therapeutic use ; Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/administration & dosage

  • Source: Lupus [Lupus] 2010 Oct; Vol. 19 (11), pp. 1281-9. Date of Electronic Publication: 2010 Jul 06.Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  62 results for ""CYCLOSPORINE""